Medical News

RSS

Advaxis receives $244,479 QTDP credit for ADXS11-001 trial

Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company was awarded a Qualifying Therapeutic Discovery Project (QTDP) credit from the Federal Government for ADXS11-001, the Company's lead immunotherapeutic construct totaling $244,479.

12 Nov 2010

New A.D.A.M. Health Navigator for hospital, healthcare websites

A.D.A.M., Inc., a leading provider of health information and benefits technology solutions, announced today that the company will unveil the new A.D.A.M. Health Navigator at the 14th Annual Healthcare Internet Conference in Las Vegas, November 15th - 17th.

12 Nov 2010

Calif. nurses emerge as political force; Iowa official under fire for strict policy on nursing home inspections; new 'homey' facilities for seniors increasing

One of California's most powerful political players these days is a Bay Area-based nurses' union, which helped torpedo Republican Meg Whitman's efforts to become governor and boosted the prospects of the eventual winning candidate, Democrat Jerry Brown.

12 Nov 2010

NIH/NIDCR awards $1.1 million grant to Agenta for soft tissue healing development

Agenta Biotechnologies, Inc., a private biotechnology company, announced that it has received a $1.1 million grant from the National Institutes of Health and National Institute of Dental and Craniofacial Research (NIH/NIDCR) for the further development of a biologically activated membrane to improve soft tissue healing associated with oral surgery.

12 Nov 2010

Study finds arsenic improves survival rate in APL patients

Arsenic, a toxic compound with a reputation as a good tool for committing homicide, has a significant positive effect on the survival of patients with acute promyelocytic leukemia (APL), when administered after standard initial treatment, according to a new, multi-center study led by a researcher at Wake Forest University Baptist Medical Center.

12 Nov 2010

Stanford University scientist receives HFSP Nakasone Award for neuronal network study

The first HFSP Nakasone Award has been conferred upon Karl Deisseroth of Stanford University for his pioneering work on the development of optogenetic methods for studying the function of neuronal networks underlying behavior.

12 Nov 2010

Nature News examines meningitis vaccine program to roll out in Africa

Nature News reports on an immunization campaign kicking off in Africa in December that will offer protection to some areas of Africa's meningitis belt. Millions will receive a new vaccine, MenAfriVac, that promises protection against the meningococcal bacterium Neisseria meningitides, the news service writes, noting the effort is the culmination of ten years' work by an international consortium to develop a vaccine at a price low enough for massive use in Africa: just US$0.40 a dose.

12 Nov 2010

NexBio presents Fludase data for Influenza-Like Illness at ACAAI 2010

NexBio, Inc. announced the presentation of new data at the 2010 annual American College of Allergy, Asthma, and Immunology in Phoenix, Arizona. The presentation was entitled DAS181 (Fludase), a Sialidase, Decreases Airway Resistance by Modulating Muscarinic Receptor Signaling.

12 Nov 2010

Kaiser Permanente announces 2011 plans for Medicare-eligible beneficiaries

Kaiser Permanente has announced its 2011 plans for individual Medicare-eligible beneficiaries, reflecting its commitment to continuing participation in Medicare in all its existing service areas in nine states and the District of Columbia.

12 Nov 2010

SCYNEXIS receives four grants under QTDP program to develop cyclophilin inhibitors

Drug discovery and development company SCYNEXIS, Inc. today announced that the Company has been awarded four grants totaling $977,917 under the U.S. Federal Government's Qualifying Therapeutic Discovery Project (QTDP). SCYNEXIS is developing a proprietary internal pipeline of cyclophilin inhibitors, a class of drugs that hold significant potential for the treatment of a broad range of diseases.

11 Nov 2010

Mobile health summit ends

The three-day mHealth Alliance summit wrapped up on Wednesday after discussions and seminars that aimed to advance the discussion around ways mobile technology can increase the access, efficiency and effectiveness of health systems, allAfrica.com reports.

11 Nov 2010

FDA grants SEDASYS System appeal

Ethicon Endo-Surgery, Inc. (EES) today announced that the Commissioner's Office of the U.S. Food and Drug Administration (FDA) has granted the appeal of the Center for Devices and Radiological Health's (CDRH) denial of the SEDASYS System Premarket Approval Application (PMA). As a result, a new Independent Advisory Panel will be appointed to reconsider the SEDASYS System clinical trial data and application.

11 Nov 2010

Roche, CapitalBio to initiate strategic partnership for molecular diagnostic applications

Roche Diagnostics and CapitalBio have announced their intention to initiate a strategic partnership targeting molecular diagnostic applications and the development of technologies to fill the unmet needs of researchers worldwide. This new development builds on the genomics and diagnostics expertise of the two companies and will focus on furthering microarray technologies and complementary products for molecular diagnostic applications.

From Roche Sequencing and Life Science 11 Nov 2010

U.N. member states elect countries to serve on U.N. women board

U.N. Member States on Wednesday voted on the countries that would have a seat on the board of U.N. Women, the new agency tasked with promoting equality and women's rights, Public Radio International's The World reports.

11 Nov 2010

StemCyte receives two cash grants under QTDP program for biomedical research

StemCyte, Inc., one of the world's preeminent umbilical cord blood (UCB) banks and biotherapy companies, is proud to announce that the Company has been awarded two cash grants totaling $488,950 under the U.S. Internal Revenue Service's Qualifying Therapeutic Discovery Project (QTDP) program designed to support biomedical research by firms with fewer than 250 employees.

11 Nov 2010

NCI awards $11.5 million to Fred Hutchinson Center for breast cancer research

The National Cancer Institute has awarded $11.5 million to Fred Hutchinson Cancer Research Center to lead a five-year, Seattle-based breast cancer research consortium. The goal of the endeavor is to positively impact breast cancer prevention, detection, treatment and care of women who have or are at risk for the disease.

11 Nov 2010

PharmAthene third quarter revenue decreases from $6.8 million to $6.2 million

PharmAthene, Inc. a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results for the third quarter and nine months ended September 30, 2010.

11 Nov 2010

Bay Area health care start-up investments down 35% in third quarter

In California's Bay Area, third-quarter venture capital investment in health care-related companies totaled $421.5 million, down 35 percent from $650.6 million in the same period a year earlier, according to research firm VentureSource.

11 Nov 2010

NephRx initiates NX001 Phase I clinical trial to prevent DGF in kidney transplant patients

NephRx Corporation today announced that it has initiated a Phase I clinical trial of its lead compound NX001 and has successfully dosed the first subject in the study. NX001, a kidney growth factor peptide that has demonstrated good safety and promising efficacy in two animal models of acute renal failure, is in development for the prevention of delayed graft function (DGF) in kidney transplantation patients.

11 Nov 2010

Meridian fourth quarter net sales decrease 16% to $35.5 million

Meridian Bioscience, Inc., reported fourth quarter and full-year fiscal 2010 net sales of $35.5 million and $143.0 million, respectively, decreases of 16% and 4%, respectively, from the same periods of the prior fiscal year.

11 Nov 2010